![](/img/cover-not-exists.png)
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer
Daniel T. Milton, Christopher G. Azzoli, Robert T. Heelan, Ennapadam Venkatraman, Jorge E. Gomez, Mark G. Kris, Lee M. Krug, William Pao, Naiyer A. Rizvi, Megan Dunne, Vincent A. MillerVolume:
107
Year:
2006
Language:
english
Pages:
8
DOI:
10.1002/cncr.22088
File:
PDF, 101 KB
english, 2006